TAYLOR MCKEOWEN: Open Payments
NPI 1669995825 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 19 payments from 10 companies in 2025. Trend: 2023 $501 · 2024 $1,104 · 2025 $1,003
Food & beverage: $1,003
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $260 |
| Novo Nordisk Inc | 3 | $183 |
| AKEBIA THERAPEUTICS INC | 3 | $177 |
| Travere Therapeutics, Inc. | 1 | $144 |
| AstraZeneca Pharmaceuticals LP | 2 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $54 |
| Lilly USA, LLC | 2 | $39 |
| GlaxoSmithKline, LLC. | 1 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: Ozempic, Vafseo, Filspari, TAVNEOS, KRYSTEXXA, Kerendia, LOKELMA, JARDIANCE.
Industry payments across SC — which companies pay providers there.
